Hancock Jaffe Laboratories Inc Razão de venda descoberta
Qual é o Razão de venda descoberta de Hancock Jaffe Laboratories Inc?
O Razão de venda descoberta de Hancock Jaffe Laboratories Inc é 0.32
Qual é a definição de Razão de venda descoberta?
Razão da venda descoberta é o número de acções vendidas a descoberto dividido pelo volume médio diário.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Razão de venda descoberta de empresas na Setor Health Care em NASDAQ em comparação com Hancock Jaffe Laboratories Inc
O que Hancock Jaffe Laboratories Inc faz?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Empresas com razão de venda descoberta semelhantes a Hancock Jaffe Laboratories Inc
- Yangtze River Port and Logistics Ltd tem Razão de venda descoberta de 0.31
- Jupai Ltd tem Razão de venda descoberta de 0.31
- TORC Oil & Gas tem Razão de venda descoberta de 0.31
- Zhangmen Education tem Razão de venda descoberta de 0.31
- Nicola Mining tem Razão de venda descoberta de 0.31
- Invesco Municipal Opportunity Trust tem Razão de venda descoberta de 0.31
- Hancock Jaffe Laboratories Inc tem Razão de venda descoberta de 0.32
- Last Mile tem Razão de venda descoberta de 0.33
- Bitcoin Well Inc tem Razão de venda descoberta de 0.33
- Euro Manganese tem Razão de venda descoberta de 0.33
- Quebec Precious Metals tem Razão de venda descoberta de 0.33
- Collective Growth tem Razão de venda descoberta de 0.33
- FRNT tem Razão de venda descoberta de 0.33